GlaxoSmithKline plc Price, Chart & Factor Analysis
Free Data & Analytics AccessNext earnings: Wed, Feb 3, 2027, before the market opens · estimates and history
GlaxoSmithKline plc Forecast
GlaxoSmithKline plc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 36.6% a year, a typical one-standard-deviation range is 889.58–986.42 over a week, 838.78–1,037 over a month and 594.28–1,282 over a year. (Signals as of 5 Nov 2026.)
GlaxoSmithKline plc Price Chart
GlaxoSmithKline plc Factors
Research on GlaxoSmithKline plc
Explore MacroFinance macro & markets research and analysis.
GlaxoSmithKline plc Trading Strategies
28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to GlaxoSmithKline plc; 2 of them are invested now. Strategies currently invested are listed first.
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
About GlaxoSmithKline plc (Mexico)
GlaxoSmithKline plc is a listed security in Mexico. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
Frequently asked questions
What is GlaxoSmithKline plc?
What is the latest GlaxoSmithKline plc price?
Is GlaxoSmithKline plc in an uptrend?
How volatile is GlaxoSmithKline plc?
What factors affect GlaxoSmithKline plc?
Which trading strategies trade GlaxoSmithKline plc?
Where can I download free GlaxoSmithKline plc historical data?
Free GlaxoSmithKline plc historical data (last 10 years)
Browse or instantly download the last 10 years of GlaxoSmithKline plc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GSKN.MX&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-19 | 960 |
| 2026-11-18 | 960 |
| 2026-11-17 | 960 |
| 2026-11-13 | 960 |
| 2026-11-12 | 959.548 |
| 2026-11-11 | 959.548 |
| 2026-11-10 | 959.548 |
| 2026-11-09 | 959.548 |
| 2026-11-06 | 951.621 |
| 2026-11-05 | 929.813 |
About this stock
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.